Literature DB >> 8593575

Distribution of mu-calpain proenzyme in the brain and other neural tissues in the rat.

K Onizuka1, M Kunimatsu, Y Ozaki, K Muramatsu, M Sasaki, H Nishino.   

Abstract

We raised antibodies against the acetyl N-terminal peptide of the human mu-calpain 80 kDa (80 K) subunit (N-acetyl SEETPVYCT-GVSAQVQKQRARELG) in the rabbit. A specific antibody was purified using N-acetyl SEEITPVYCTGVSAQVQKQ peptide-conjugated Sepharose 4B as an affinity gel support. Epitope analysis revealed that the purified antibody reacted only with mu-calpain N-terminal peptides containing N-acetyl SEETT structure but no reactions occurred with other analogous peptides. Western blot analysis showed that the antibody reacted with both human and rat mu-calpain proenzymes but not with the activated calpains lacking N-terminal peptide. Using this antibody we investigated immunohistochemically the distribution of mu-calpain proenzyme in central and peripheral nervous systems as well as other non-neural tissues in the rat. The proenzyme was detected mainly in neurons both in the central and peripheral nervous tissues, but not in non-neural tissues except for red blood cells. Immunoreaction was stronger in the perikarya and/or in the nuclei than in-the cytoplasm. Specificity of the antibody was verified by an absorption test. In summary, the mu-calpain proenzyme is mainly distributed in the perikarya and/or nuclei or neurons. Our present antibody specific to the N-terminus of the mu-calpain 80 K subunit could serve as a useful tool to detect various functions of mu-calpain as well as the damage in neurons caused by the enzyme.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593575     DOI: 10.1016/0006-8993(95)00838-h

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Protective effects of calpain inhibitor for prolonged hypothermic cardiac preservation.

Authors:  T Saito; A Mishima; M Asano; T Ukai; S Yamamoto; M Kunimatsu; M Sasaki; T Manabe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-04

Review 2.  Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease.

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Brain Res Brain Res Rev       Date:  2005-01-08

Review 3.  Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better?

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2005-01       Impact factor: 1.990

4.  Screening for motility-associated genes in malignant astrocytoma cell lines.

Authors:  Hyang-Hwa Ryu; Shin Jung; Heung-Suk Sun; Tae-Young Jung; Shu-Guang Jin; Yong-Hao Jin; In-Young Kim; Young-Il Jeong; Sam-Suk Kang
Journal:  J Neurooncol       Date:  2006-10-18       Impact factor: 4.130

5.  Proteolytic degradation of SCOP in the hippocampus contributes to activation of MAP kinase and memory.

Authors:  Kimiko Shimizu; Trongha Phan; Isabelle M Mansuy; Daniel R Storm
Journal:  Cell       Date:  2007-03-23       Impact factor: 41.582

6.  A possible therapeutic potential of quercetin through inhibition of μ-calpain in hypoxia induced neuronal injury: a molecular dynamics simulation study.

Authors:  Anand Kumar Pandey; Swet Chand Shukla; Pallab Bhattacharya; Ranjana Patnaik
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.